🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as cetuximab, can block tumor growth...
Status
Completed
Location
M.D. Anderson Cancer Center at University of Texas
Start Date
2006-04
Trial ID
NCT00301028
Treatments Being Tested
This prospective, observational, multicentre, post marketing surveillance s...
Status
Terminated
Location
Omega Hospital
Start Date
2011-02-28
Trial ID
NCT01303237
Treatments Being Tested
Primary Objective for Phase I 1. To determine the maximally tolerated dose...
Status
Terminated
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2009-07
Trial ID
NCT00882583
Treatments Being Tested
This is a Phase I dose-escalation study of sEphB4-HSA in combination with c...
Status
Completed
Location
University of Colorado Hospital
Start Date
2020-01-06
Trial ID
NCT04091867
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as cetuximab, can block tumor growth...
Status
Terminated
Location
Mobile Infirmary Medical Center
Start Date
2005-05
Trial ID
NCT00109850
Treatments Being Tested
The aim of this study is to evaluate the rate of living patients at 1 year ...
Status
Active Not Recruiting
Location
Hôpital Nord Franche Comté
Start Date
2015-09-21
Trial ID
NCT03070366
Treatments Being Tested
This phase II trial studies how well radiation therapy and cisplatin with o...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2020-01-14
Trial ID
NCT04106362
Treatments Being Tested
This is a single-arm, phase II trial to characterize the clinical outcome o...
Status
Terminated
Location
University of Michigan Medical Center
Start Date
2009-04
Trial ID
NCT00904345
Treatments Being Tested
RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. D...
Status
Completed
Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Start Date
2005-11
Trial ID
NCT00265941
RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different...
Status
Terminated
Location
Alaska Regional Hospital Cancer Center
Start Date
2006-04
Trial ID
NCT00288054
Treatments Being Tested